These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28106468)

  • 1. Proceedings of BMRES Altitude Medicine Conference: November 26th, 2016, Birmingham, United Kingdom.
    Gault LE; Lewis CT; Lock HE
    High Alt Med Biol; 2017 Mar; 18(1):80-81. PubMed ID: 28106468
    [No Abstract]   [Full Text] [Related]  

  • 2. Report of proceedings of BMRES Altitude Medicine Conference November 22, 2013 at the Birmingham Medical Institute, Birmingham, United Kingdom.
    Thomas O; Booth A
    High Alt Med Biol; 2014 Apr; 15(1):89-90. PubMed ID: 24673537
    [No Abstract]   [Full Text] [Related]  

  • 3. UK high altitude research: a report from the Birmingham Medical Research Expeditionary Society (BMRES) altitude research conference, December 4, 2009, held at the Birmingham Medical Institute, United Kingdom.
    Kalson NS; Stubbings AH; Collins HL; Pattinson KT; Wright AD
    Wilderness Environ Med; 2010 Jun; 21(2):181-2. PubMed ID: 20591393
    [No Abstract]   [Full Text] [Related]  

  • 4. Advancing the evidence in altitude and wilderness medicine.
    Zafren K; Shlim DR; Basnyat B; Visser J
    J Travel Med; 2020 Sep; 27(6):. PubMed ID: 32761151
    [No Abstract]   [Full Text] [Related]  

  • 5. Wilderness Medical Society consensus guidelines for the prevention and treatment of acute altitude illness--a view from the other side of the Atlantic.
    Hillebrandt D
    Wilderness Environ Med; 2010 Dec; 21(4):383-4; author reply 384-5. PubMed ID: 21168796
    [No Abstract]   [Full Text] [Related]  

  • 6. Are UK commercial expeditions complying with wilderness medical society guidelines on ascent rates to altitude?
    Shah NM; Windsor JS; Meijer H; Hillebrandt D
    J Travel Med; 2011; 18(3):214-6. PubMed ID: 21539665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personal use of performance-enhancing drugs at high altitude.
    Mulroy P
    Wilderness Environ Med; 2013 Jun; 24(2):172-3. PubMed ID: 23434164
    [No Abstract]   [Full Text] [Related]  

  • 8. Medical and sporting ethics of high altitude mountaineering: the use of drugs and supplemental oxygen.
    Wagner DR
    Wilderness Environ Med; 2012 Sep; 23(3):205-6. PubMed ID: 22921193
    [No Abstract]   [Full Text] [Related]  

  • 9. "Performance enhancing" drugs at high altitude.
    Zafren K; Berghold F; Hillebrandt D
    Wilderness Environ Med; 2013 Jun; 24(2):173-4. PubMed ID: 23434166
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk Stratification for Athletes and Adventurers in High-Altitude Environments: Recommendations for Preparticipation Evaluation.
    Campbell AD; McIntosh SE; Nyberg A; Powell AP; Schoene RB; Hackett P
    Clin J Sport Med; 2015 Sep; 25(5):404-11. PubMed ID: 26340732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary study of the effect of menstruation on the incidence of acute mountain sickness.
    Paul ME; Wagner TD; Tukel CA; Levin DR
    Emerg Med J; 2023 May; 40(5):333-334. PubMed ID: 36792343
    [No Abstract]   [Full Text] [Related]  

  • 12. Wilderness Medical Society practice guidelines for the prevention and treatment of acute altitude illness: 2014 update.
    Luks AM; McIntosh SE; Grissom CK; Auerbach PS; Rodway GW; Schoene RB; Zafren K; Hackett PH;
    Wilderness Environ Med; 2014 Dec; 25(4 Suppl):S4-14. PubMed ID: 25498261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do British commercial mountaineering expeditions carry drugs to treat high altitude illnesses?
    Pattenden HA; Shah NM; Hillebrandt D; Rodger M; Windsor JS
    J Travel Med; 2012 Jul; 19(4):250-2. PubMed ID: 22776387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do UK trekking companies recommend prophylactic acetazolamide for expeditions to Mount Kilimanjaro?
    Hadley R; Veremu M; McMaster D
    J Travel Med; 2021 Jan; 28(1):. PubMed ID: 32856060
    [No Abstract]   [Full Text] [Related]  

  • 15. Wilderness Medical Society consensus guidelines for the prevention and treatment of acute altitude illness.
    Luks AM; McIntosh SE; Grissom CK; Auerbach PS; Rodway GW; Schoene RB; Zafren K; Hackett PH;
    Wilderness Environ Med; 2010 Jun; 21(2):146-55. PubMed ID: 20591379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fighting in thin air: operational wilderness medicine in high Asia.
    Rodway GW; Muza SR
    Wilderness Environ Med; 2011 Dec; 22(4):297-303. PubMed ID: 22137862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High altitude medicine: a British perspective.
    Milledge JS
    High Alt Med Biol; 2003; 4(3):261-4. PubMed ID: 14561232
    [No Abstract]   [Full Text] [Related]  

  • 18. What to Expect Working as a Doctor at a High-Altitude Aid Post.
    Systermans B; Stokes S
    High Alt Med Biol; 2019 Dec; 20(4):325-330. PubMed ID: 31599660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deaths during mountaineering at extreme altitude.
    Pollard A; Clarke C
    Lancet; 1988 Jun; 1(8597):1277. PubMed ID: 2897536
    [No Abstract]   [Full Text] [Related]  

  • 20. Performance-enhancing drugs-commentaries.
    Cushing TA; McIntosh SE; Keyes LE; Rodway GW; Schoene RB; Basnyat B; Freer L
    Wilderness Environ Med; 2012 Sep; 23(3):207-11. PubMed ID: 22921194
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.